Home
Issues
Aim & Scope
Open Access
Indexing
Why publish with us
Contact
Editorial Board
Instructions to Authors (PDF)
Manuscript Types
Manuscript Formatting
How to submit
Preprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
Data Policies
IMAGES IN PNEUMONOLOGY
The therapeutic potential of inhaled-GM-CSF in severe a-PAP
| 1 | 2nd Pulmonary Medicine Department,
General University Hospital "Attikon",
Medical School, National and Kapodistrian
University of Athens, Greece |
| 2 | 7th Pulmonary Department, Athens Chest
Hospital "Sotiria", Athens Greece |
| 3 | 2nd Department of Radiology, General
University Hospital "Attikon", Medical School,
National and Kapodistrian University
of Athens, Greece |
| 4 | Department of Pediatric Pneumology,
Dr von Hauner Children's Hospital, Ludwig-Maximilians-University, German Center
for Lung Research, Germany |
CORRESPONDING AUTHOR
Spyros A. Papiris
2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece 1 Rimini Street, 12462, Haidari, Greece
2nd Pulmonary Medicine Department, General University Hospital "Attikon", Medical School, National and Kapodistrian University of Athens, Greece 1 Rimini Street, 12462, Haidari, Greece
Pneumon 2020;33(2):1–2
KEYWORDS
This is to certify that the images have not been previously published and that the patient has provided written permission to publish the case.
REFERENCES (5)
1.
Tazawa R, Trapnell BC, Inoue Y, et al. Inhaled granulocyte/ macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2010; 181:1345-54.
2.
Papiris SA, Tsirigotis P, Kolilekas L, et al. Long-term inhaled Granulocyte Macrophage-Colony Stimulating Factor in Autoimmune Pulmonary Alveolar Proteinosis: Effectiveness, safety, lowest-effective dose. Clin Drug Invest 2014; 34:553-64.
3.
Papiris SA, Tsirigotis P, Kolilekas L, et al. Pulmonary Alveolar Proteinosis: Time to shift. Expert Rev Respir Med 2015; 9:337-49.
4.
Tazawa R, Ueda T, Abe M, et al. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. N Engl J Med 2019; 381:923-32.
5.
Papiris SA, Griese M, Manali ED. Inhaled GM-CSF for Pulmonary Alveolar Proteinosis. N Engl J Med 2020; 382:197.
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.